References,Sample size,Interventions,Main race,Female (%),Mean HAMA,Mean age (Year),Attrition rate (%),Sponsor,Follow-up time (weeks),Diagnosis criteria
"Feltner et al., 2003",271,pregabalin: 150 mg/day,White,51.4,24.9,37.9,24.3,Pfizer Global Research and Development,4,dsm-iv
"Feltner et al., 2003",271,pregabalin: 600 mg/day,White,50.0,25.4,36.3,30.3,Pfizer Global Research and Development,4,dsm-iv
"Feltner et al., 2003",271,lorazepam: 6 mg/day,White,58.8,24.7,39.2,47.1,Pfizer Global Research and Development,4,dsm-iv
"Feltner et al., 2003",271,placebo,White,50.7,24.8,37.8,28.4,Pfizer Global Research and Development,4,dsm-iv
